Clinical trials
Withdrawn Lymphoproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2013 | 1 |
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Leland Metheny | 1 |
| Nordic Nanovector | 1 |
| Oncternal Therapeutics, Inc | 1 |
| University of California, San Diego | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 9 |
| Lymphoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma, Mantle-Cell | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Hodgkin Disease | 5 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Lymphoma, Extranodal NK-T-Cell | 5 |
| Lymphoma, Follicular | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
Trials
Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.